Citation: N. Savion et al., PLATELET PROTECTION BY APROTININ IN CARDIOPULMONARY BYPASS - AGGREGATION ON EXTRACELLULAR-MATRIX, Thrombosis and haemostasis, 69(6), 1993, pp. 693-693
Citation: Fp. Driscoll et R. Mohr, SIGNING OFF - MOHR,RICHARD, PRODUCER OF THE METS INTERMISSION-FEATURES, STEPS DOWN AFTER 12 YEARS( AN INTERVIEW ), Opera news, 58(2), 1993, pp. 33
Authors:
MOSHKOVITZ Y
VERED Z
MOTRO M
SMOLINSKY A
MOHR R
ZISKIND Z
Citation: Y. Moshkovitz et al., TRICUSPID-VALVE SURGERY - RECENT EXPERIENCE AT THE CHAIM-SHEBA-MEDICAL-CENTER, Israel journal of medical sciences, 29(11), 1993, pp. 703-706
Citation: Y. Moshkovitz et R. Mohr, CORONARY-ARTERY BYPASS WITHOUT CARDIOPULMONARY BYPASS - THE PROS AND THE CONS, Israel journal of medical sciences, 29(11), 1993, pp. 716-720
Citation: R. Mohr et al., EHT MODEL STUDIES ON COORDINATION-SPHERE EFFECTS IN THE ELEMENTARY STEPS OF D0 TRANSITION-METAL-CATALYZED ZIEGLER-NATTA POLYMERIZATION, Helvetica Chimica Acta, 76(3), 1993, pp. 1389-1409
Authors:
MOHR R
MEDALION B
SHINFELD A
SHINAR E
LAVEE J
Citation: R. Mohr et al., HIGH-DOSE APROTININ IMPROVES HEMOSTASIS AFTER OPEN-HEART BETTER THAN TRANSFUSION OF SINGLE-DONOR PLATELET CONCENTRATE, Circulation, 88(4), 1993, pp. 265-265
Citation: R. Mohr et al., CORONARY-ARTERY BYPASS WITHOUT CARDIOPULMONARY BYPASS - LOW-RISK SURGERY FOR HIGH-RISK PATIENTS, Circulation, 88(4), 1993, pp. 637-637